Cd44 Targeting

CD44 Targeting is a ligand-mediated targeting strategy that specifically directs therapeutic or diagnostic agents to cells overexpressing the CD44 receptor, a transmembrane glycoprotein associated with cancer stemness, inflammation, and tissue homing, by exploiting the high-affinity interaction between CD44 and its ligands such as hyaluronic acid.

556

Publications

36.1K

Citations

3.8K

Authors

1K

Institutions

Publications per year

2017–2026

282

Authors

3.8K

  1. ZZ
    Zhiyuan Zhong

    Soochow University, China

    15 publications · 1.1K citations

    15

    h-index

  2. DC
    Daquan Chen

    Yantai University, China

    10 publications · 403 citations

    10

    h-index

  3. FM
    Fenghua Meng

    Soochow University, China

    10 publications · 801 citations

    10

    h-index

  4. CD
    Chao Deng

    Soochow University, China

    8 publications · 686 citations

    8

    h-index

  5. TG
    Tao Gong

    Sichuan University, China

    7 publications · 316 citations

    6

    h-index

1–5 of 3.8K

Venues

  1. Journal of Controlled Release

    16 publications · 1.5K citations

    15

    h-index

  2. Blood

    15 publications · 1.2K citations

    13

    h-index

  3. ACS Applied Materials & Interfaces

    13 publications · 1K citations

    13

    h-index

  4. Biomacromolecules

    12 publications · 964 citations

    12

    h-index

  5. International Journal of Nanomedicine

    13 publications · 582 citations

    12

    h-index

1–5